Literature DB >> 17880760

IL-8 and pH values in exhaled condensate after antibiotics in cystic fibrosis children.

A Bodini1, C D'Orazio, D G Peroni, M Corradi, L Zerman, G Folesani, B M Assael, A L Boner, G L Piacentini.   

Abstract

Interleukin (IL)-8 is a major factor in inflammatory response and the IL-8 levels in exhaled breath condensate (EBC) may be used as a marker of airway inflammation. Airway acidification is implicated in the pathophysiology of obstructive airway diseases and pH EBC values have been used as a marker of airway acidification. The aim of our study is to investigate whether IL-8 and pH levels in EBC of cystic fibrosis (CF) children with respiratory exacerbations change after antibiotic treatment. Lung function, IL-8 and pH EBC values were measured in fifteen CF children (mean age 11 years) with acute exacerbation before (T0) and after two weeks (T1) of antibiotic treatment. IL-8 and pH values were compared by paired t-test. A p less than 0.05 was considered significant. IL-8 EBC levels decreased after antibiotic treatment (T0 0.36+/-0.03pg/ml vs T1 0.28+/-0.03pg/ml; p=0.03) and pH values increased (T0 7.36+/-0.09 vs T1 7.61+/-0.08; p=0.04). Results suggest possible application of EBC as a non-invasive tool to monitor efficacy of antibiotic treatment in CF patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17880760     DOI: 10.1177/039463200702000305

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  7 in total

Review 1.  Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.

Authors:  Olivia Giddings; Charles R Esther
Journal:  Pediatr Pulmonol       Date:  2017-07-17

2.  Exhaled breath condensate pH in patients with cystic fibrosis.

Authors:  Balazs Antus; Imre Barta; Eszter Csiszer; Krisztina Kelemen
Journal:  Inflamm Res       Date:  2012-06-16       Impact factor: 4.575

Review 3.  Novel end points for clinical trials in young children with cystic fibrosis.

Authors:  Shannon J Simpson; Lauren S Mott; Charles R Esther; Stephen M Stick; Graham L Hall
Journal:  Expert Rev Respir Med       Date:  2013-06       Impact factor: 3.772

4.  Elevated expression of both mRNA and protein levels of IL-17A in sputum of stable Cystic Fibrosis patients.

Authors:  Ann Decraene; Anna Willems-Widyastuti; Ahmad Kasran; Kris De Boeck; Dominique M Bullens; Lieven J Dupont
Journal:  Respir Res       Date:  2010-12-10

Review 5.  Exhaled Breath Condensate: Technical and Diagnostic Aspects.

Authors:  Efstathia M Konstantinidi; Andreas S Lappas; Anna S Tzortzi; Panagiotis K Behrakis
Journal:  ScientificWorldJournal       Date:  2015-05-27

Review 6.  Breath tests in respiratory and critical care medicine: from research to practice in current perspectives.

Authors:  Attapon Cheepsattayakorn; Ruangrong Cheepsattayakorn
Journal:  Biomed Res Int       Date:  2013-09-18       Impact factor: 3.411

7.  Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.

Authors:  Marieke van Horck; Ariel Alonso; Geertjan Wesseling; Karin de Winter-de Groot; Wim van Aalderen; Han Hendriks; Bjorn Winkens; Ger Rijkers; Quirijn Jöbsis; Edward Dompeling
Journal:  PLoS One       Date:  2016-04-06       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.